CONSUN PHARMA (01681) spent HK$7.4928 million on November 7 to repurchase 505,000 shares.
Kangcon Pharmaceuticals (01681) announced that it will spend HK$7.4928 million to repurchase 5 million...
CONSUN PHARMA (01681) announces that on November 7, 2025, it will spend HK$7.4928 million to repurchase 505,000 shares.
Related Articles
US Stock Market Move | Rare earth concept stocks have varying ups and downs. MP Materials (MP.US) rose over 5.7%.
US Stock Market Move | Century Aluminum Company (CENX.US) surged more than 17% and its Q3 revenue exceeded expectations.
US Stock Market Move | Genpact Limited (G.US) surged more than 14% as Q3 revenue exceeded expectations, raising 2025 sales guidance.
US Stock Market Move | Rare earth concept stocks have varying ups and downs. MP Materials (MP.US) rose over 5.7%.
US Stock Market Move | Century Aluminum Company (CENX.US) surged more than 17% and its Q3 revenue exceeded expectations.
US Stock Market Move | Genpact Limited (G.US) surged more than 14% as Q3 revenue exceeded expectations, raising 2025 sales guidance.
RECOMMEND
Short Positions on Xiaomi (01810.HK) Surge 53% in a Week as Memory Price Spike Weighs on Sentiment
07/11/2025
Privatization Wave in Hong Kong Stocks: Exiting Liquidity Traps to Enable Strategic Transformation
07/11/2025
Over 30 Foreign Firms Attend Roundtable as Ministry of Commerce Signals Multiple Policy Shifts
07/11/2025
